Disclosures for "Clinical Utility of Skin Biopsy Compared to DaTscan in Diagnosing Synucleinopathies")
-
Dr. Urval has nothing to disclose.
-
Dr. Meytin has nothing to disclose.
-
Dr. Dorfman has nothing to disclose.
-
Dr. Lahrmann has nothing to disclose.
-
Dr. Bortan has nothing to disclose.
-
Dr. Dagostine has received personal compensation for serving as an employee of Adamas. Dr. Dagostine has received personal compensation for serving as an employee of Neurocrine. Dr. Dagostine has received personal compensation for serving as an employee of Boston Scientific. Dr. Dagostine has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Adamas. Dr. Dagostine has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Dagostine has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Adamas. Dr. Dagostine has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine.
-
Dr. Duffy has stock in Meru Health.
-
An immediate family member of Dr. Moro-de-Casillas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. An immediate family member of Dr. Moro-de-Casillas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intuitive. The institution of Dr. Moro-de-Casillas has received research support from Davis Phinney Foundation.
-
Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
-
Dr. Kanchana has nothing to disclose.
-
Dr. DeMarcaida has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. DeMarcaida has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. DeMarcaida has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda. Dr. DeMarcaida has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. The institution of Dr. DeMarcaida has received research support from Pharma2B. The institution of Dr. DeMarcaida has received research support from Neuroderm. The institution of Dr. DeMarcaida has received research support from Addex.